Light Sciences Oncology Obtains $40,100,000 Series C Financing Round

  • Feed Type
  • Date
    7/17/2008
  • Company Name
    Light Sciences Oncology
  • Mailing Address
    15405 SE 37th Street Bellevue, WA 98006
  • Company Description
    Light Sciences Oncology is developing Light Infusion Therapy (Litx™), an innovative light-activated treatment for solid tumors. LSO is currently developing Litx™ for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy.
  • Website
    http://www.lsoncology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,100,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.